Patents by Inventor Zhanshan Yang

Zhanshan Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA molecule used for recombinant and recombinant strain expressing PprI protein of
    Patent number: 10000761
    Abstract: A DNA molecule comprising the sequence set forth in SEQ ID NO: 1, a recombinant Pichia plasmid into which the DNA molecule is inserted, and a recombinant Pichia strain obtained by the transformation of the recombinant Pichia plasmid into a competent Pichia cell and efficiently expressing the PprI protein of Deinococcus radiodurans.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: June 19, 2018
    Assignee: SOOCHOW UNIVERSITY
    Inventors: Zhanshan Yang, Wei Wu, Huiping Qiao, Ling Wen, Yi Shi, Lili Ren, Dong Yu
  • DNA MOLECULE USED FOR RECOMBINANT PICHIA PLASMID AND RECOMBINANT PICHIA STRAIN EXPRESSING PPRI PROTEIN OF DEINOCOCCUS RADIODURANS
    Publication number: 20170016009
    Abstract: A DNA molecule comprising the sequence set forth in SEQ ID NO: 1, a recombinant Pichia plasmid into which the DNA molecule is inserted, and a recombinant Pichia strain obtained by the transformation of the recombinant Pichia plasmid into a competent Pichia cell and efficiently expressing the PprI protein of Deinococcus radiodurans.
    Type: Application
    Filed: May 30, 2014
    Publication date: January 19, 2017
    Inventors: Zhanshan YANG, Wei WU, Huiping QIAO, Ling WEN, Yi SHI, Lili REN, Dong YU
  • RECOMBINANT EUKARYOTIC EXPRESSION PLASMID ENCODING pprI GENE OF DEINOCOCCUS RADIODURANS R1 AND ITS FUNCTIONS
    Publication number: 20110236933
    Abstract: The present invention concerns a novel recombinant eukaryotic expression plasmid pCMV-HA-pprI encoding the pprI gene isolated from Deinococcus radiodurans R1, the method for preparing pCMV-HA-pprI, and its expression in human 293T cells. The present invention also discloses the optimal method and process of pprI gene transfection by in vivo electroporation, and the radioprotective and therapeutic effects of the recombinant pCMV-HA-pprI on lethally irradiated mice.
    Type: Application
    Filed: March 24, 2010
    Publication date: September 29, 2011
    Applicant: SOOCHOW UNIVERSITY
    Inventors: Zhanshan Yang, Na Li, Tianchang Wang, Tingting Chen, Yongqin Zhang
  • HYDROGEL WOUND DRESSING AND ITS METHOD OF PREPARATION
    Publication number: 20090297587
    Abstract: An improved hydrogel wound dressing and its preparation is disclosed. The ingredients used in the dressing are PAAS of 20˜30 wt %, PVA of 2˜6 wt % and water of 64˜78 wt %. The hydrogel wound dressings were formed by dissolution, casting films, radiation synthesis and sterilization. Compared with conventional hydrogel dressings the improved dressings displayed an enhanced degree of swelling. Cell growth factors may be incorporated into the dressings to be released slowly in the wound.
    Type: Application
    Filed: May 22, 2009
    Publication date: December 3, 2009
    Applicant: SUZHOU UNIVERSITY
    Inventors: Zhanshan Yang, Zhigao Rao, Ling Yue, Shuqin Yang, Nankang Zhu